A targeted resequencing gene panel for focal epilepsy

Neurology

Volumn 86, Issue 17, 2016, Pages 1605-1612

  Hildebrand, Michael S ^a   Myers, Candace T ^b   Carvill, Gemma L ^b   Regan, Brigid M ^a   Damiano, John A ^a   Mullen, Saul A ^a   Newton, Mark R ^a   Nair, Umesh ^a   Gazina, Elena V ^a   Milligan, Carol J ^a   Reid, Christopher A ^a   Petrou, Steven ^a   Scheffer, Ingrid E ^a,c   Berkovic, Samuel F ^a   Mefford, Heather C ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

KCNT1 PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NICOTINIC RECEPTOR ALPHA4; PCDH19 PROTEIN; PROTEIN; SODIUM CHANNEL NAV1.1; UNCLASSIFIED DRUG; CADHERIN; KCNT1 PROTEIN, HUMAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE PROTEIN; NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA4 SUBUNIT; NICOTINIC RECEPTOR; NR2B NMDA RECEPTOR; PCDH19 PROTEIN, HUMAN; POTASSIUM CHANNEL; SCN1A PROTEIN, HUMAN;

ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; FOCAL EPILEPSY; FRONTAL LOBE EPILEPSY; GENE SEQUENCE; GENE TARGETING; GENETIC ANALYSIS; GERMLINE MUTATION; HIPPOCAMPAL SCLEROSIS; HUMAN; MAJOR CLINICAL STUDY; MESIAL TEMPORAL LOBE EPILEPSY; PHENOTYPE; PRIORITY JOURNAL; SOMATIC MUTATION; TEMPORAL LOBE EPILEPSY; TRAUMATIC EPILEPSY; COHORT ANALYSIS; DNA SEQUENCE; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; MALE; MUTATION; PROCEDURES; VALIDATION STUDY;

CADHERINS; COHORT STUDIES; EPILEPSIES, PARTIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MUTATION; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL; NERVE TISSUE PROTEINS; POTASSIUM CHANNELS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; SEQUENCE ANALYSIS, DNA;

EID: 84964807830     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002608     Document Type: Article

References (33)

1. Hildebrand MS, Dahl HH, Damiano JA, Smith RJ, Scheffer IE, Berkovic SF. Recent advances in the molecular genetics of epilepsy. J Med Genet 2013;50:271-279. doi: 10.1136/jmedgenet-2012-101448.
2. Jallon P, Loiseau P, Loiseau J. Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study. Coordination Active du Reseau Observatoire Longitudinal de l' Epilepsie. Epilepsia 2001;42:464-475.
3. King MA, Newton MR, Jackson GD, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 1998;352:1007-1011.
4. Dibbens LM, de Vries B, Donatello S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet 2013;45:546-551.
5. Heron SE, Smith KR, Bahlo M, et al. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 2012;44:1188-1190.
6. Bisulli F, Tinuper P, Scudellaro E, et al. A de novo LGI1 mutation in sporadic partial epilepsy with auditory features. Ann Neurol 2004;56:455-456.
7. Phillips HA, Marini C, Scheffer IE, Sutherland GR, Mulley JC, Berkovic SF. A de novo mutation in sporadic nocturnal frontal lobe epilepsy. Ann Neurol 2000;48: 264-267.
8. Hiatt JB, Pritchard CC, Salipante SJ, O'Roak BJ, Shendure J. Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation. Genome Res 2013;23:843-854.
9. Reutens DC, Howell RA, Gebert KE, Berkovic SF. Validation of a questionnaire for clinical seizure diagnosis. Epilepsia 1992;33:1065-1071.
10. Abou-Khalil B, Ge Q, Desai R, et al. Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation. Neurology 2001;57:2265-2272.
11. Scheffer IE, Harkin LA, Grinton BE, et al. Temporal lobe epilepsy and GEFS1 phenotypes associated with SCN1B mutations. Brain 2007;130:100-109.
12. Berkovic SF, Howell RA, Hay DA, Hopper JL. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol 1998;43:435-445.
13. Grimberg J, Nawoschik S, Belluscio L, McKee R, Turck A, Eisenberg A. A simple and efficient nonorganic procedure for the isolation of genomic DNA from blood. Nucleic Acids Res 1989;17:8390.
14. Aridon P, Marini C, Di Resta C, et al. Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet 2006;79:342-350.
15. Carvill GL, Regan BM, Yendle SC, et al. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet 2013;45:1073-1076.
16. De Fusco M, Becchetti A, Patrignani A, et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000;26:275-276.
17. Dibbens LM, Tarpey PS, Hynes K, et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet 2008;40:776-781. doi: 10.1038/ng.149.
18. Escayg A, MacDonald BT, Meisler MH, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS12. Nat Genet 2000;24:343-345.
19. Falace A, Filipello F, La Padula V, et al. TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy. Am J Hum Genet 2010;87:365-370.
20. Steinlein OK, Mulley JC, Propping P, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995;11:201-203.
21. Zarrelli MM, Beghi E, Rocca WA, Hauser WA. Incidence of epileptic syndromes in Rochester, Minnesota: 1980-1984. Epilepsia 1999;40:1708-1714.
22. Carvill GL, Heavin SB, Yendle SC, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 2013;45: 825-830. doi: 810.1038/ng.2646.
23. Milligan CJ, Li M, Gazina E, et al. KCNT1 gain-offunction in two epilepsy phenotypes is reversed by quinidine. Ann Neurol 2014;75:581-590.
24. Allen AS, Berkovic SF, Cossette P, et al. De novo mutations in epileptic encephalopathies. Nature 2013;501: 217-221. doi: 210.1038/nature12439.
25. Endele S, Rosenberger G, Geider K, et al. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 2010;42:1021-1026. doi: 1010.1038/ng.1677.
26. Hamdan FF, Srour M, Capo-Chichi JM, et al. De novo mutations in moderate or severe intellectual disability. PLoS Genet 2014;10:e1004772. doi: 10.1371/journal. pgen.1004772.
27. Lemke JR, Hendrickx R, Geider K, et al. GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy. Ann Neurol 2014;75:147-154. doi: 10.1002/ana.24073.
28. Karakas E, Simorowski N, Furukawa H. Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J 2009;28:3910-3920. doi: 10.1038/emboj.2009.338.
29. Rachline J, Perin-Dureau F, Le Goff A, Neyton J, Paoletti P. The micromolar zinc-binding domain on the NMDA receptor subunit NR2B. J Neurosci 2005;25: 308-317.
30. Colosimo E, Gambardella A, Mantegazza M, et al. Electroclinical features of a family with simple febrile seizures and temporal lobe epilepsy associated with SCN1A loss-of-function mutation. Epilepsia 2007;48: 1691-1696.
31. Kasperaviciute D, Catarino CB, Matarin M, et al. Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. Brain 2013;136:3140-3150.
32. Depienne C, Bouteiller D, Keren B, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet 2009;5:e1000381. doi: 10.1371/journal.pgen.1000381.
33. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-423. doi: 10.1038/gim.2015.30.